OCM2 as A Drug Target and Biomarker (G4951)

Target Name: OCM2

NCBI ID: G4951

OCM2 as A Drug Target and Biomarker

OCM2 (O-Chloro-2,3-dimethylbutane) is a fatty acid that is found in various organisms, including bacteria, algae, and animals. It is a primary component of the cell membrane and is involved in various cellular processes. OCM2 has also been shown to have potential as a drug target and biomarker.

OCM2 as a drug target

OCM2 has been shown to play a role in various cellular processes, including the regulation of cell signaling pathways and the maintenance of cellular structure. One of the known functions of OCM2 is its role in the regulation of the cytoskeleton. OCM2 has been shown to interact with the protein tyrosine kinase (TK) and influence the tyrosination of the protein p21 (a key regulator of the cytoskeleton). This interaction between OCM2 and TK has been shown to play a role in the regulation of cell signaling pathways, including the regulation of cell growth, differentiation, and survival.

In addition to its role in cell signaling pathways, OCM2 has also been shown to be involved in the regulation of cellular structure. OCM2 is a major component of the cell membrane and is involved in the maintenance of the cell's structural integrity. This is important for the proper functioning of the cell, as a disrupted cell membrane can lead to various cellular problems, including cell death and disease.

OCM2 as a biomarker

OCM2 has also been shown to have potential as a biomarker for various diseases, including cancer. OCM2 has been shown to be expressed in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, studies have shown that OCM2 levels are often elevated in cancer tissues compared to healthy tissue. This suggests that OCM2 may be a useful biomarker for cancer diagnosis and monitoring.

OCM2 has also been shown to be involved in the regulation of cellular processes that are important for cancer progression. For example, OCM2 has been shown to play a role in the regulation of the angiogenic switch, which is the process by which cancer cells develop the ability to grow and metastasize. Additionally, OCM2 has been shown to influence the migration of cancer cells.

OCM2 as a drug target

OCM2 has also been shown to be a potential drug target for various diseases, including cancer. OCM2 has been shown to interact with various proteins, including the protein tyrosine kinase (TK) and the transcription factor nuclear factor E2F1. These interactions suggest that OCM2 may be a useful target for drugs that target these proteins.

One of the potential mechanisms by which OCM2 may be a drug target is its role in the regulation of cell signaling pathways. OCM2 has been shown to interact with TK and influence the tyrosination of the protein p21. This interaction suggests that OCM2 may be a useful target for drugs that target TK and inhibit tyrosination of p21.

Another potential mechanism by which OCM2 may be a drug target is its role in the regulation of cellular structure. OCM2 is involved in the maintenance of cellular structure and may be a useful target for drugs that disrupt this structure and cause cellular problems, such as cancer.

OCM2 as a biomarker

OCM2 has also been shown to have potential as a biomarker for various diseases, including cancer. OCM2 has been shown to be expressed in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, studies have shown that OCM2 levels are often elevated in cancer tissues compared to healthy tissue. This suggests that OCM2 may be a useful biomarker for cancer diagnosis and monitoring.

OCM2 has also been shown to be involved in

Protein Name: Oncomodulin 2

More Common Targets